Duanyu Wang
No.253 Mid Gongye Ave, Haizhu District
Guangzhou, 510282, China
Guangzhou, 510282, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Hpv-driven rewiring of the tumor immune microenvironment through single-cell profiling informs prognosis and therapy in HNSCC.
Journal: Oral oncology
Published: September 17, 2025
EPB41L3 as a prognostic biomarker suppressing cellular malignancy and correlating with the immune microenvironment in glioma.
Journal: Biochemical and biophysical research communications
Published: April 09, 2025
Unveiling the multifaceted role of the FLNC gene: implications for cancer diagnosis and prognosis.
Journal: European journal of medical research
Published: January 08, 2025
Unveiling the immunological terrain of pancreatic ductal adenocarcinoma: strategies to prompt immunotherapy from Mendelian randomization.
Journal: Discover oncology
Published: November 19, 2024
Basophils may as a risk factor for upper gastrointestinal cancer: a Mendelian randomization (MR) study.
Journal: Ecancermedicalscience
Published: July 08, 2024
Causal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study.
Journal: Molecular medicine reports
Published: July 01, 2024
The causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomization (MR).
Journal: Ecancermedicalscience
Published: February 19, 2024
Phosphate-to-alanine ratio and bilirubin-to-androsterone glucuronide ratio are the hub metabolites in upper gastrointestinal cancers: a Mendelian randomisation (MR) study.
Journal: Ecancermedicalscience
Published: February 12, 2024
Comparative analysis of immune checkpoint inhibitors in first-line treatment of esophageal squamous cell carcinoma: a network meta-analysis.
Journal: Immunotherapy
Published: May 04, 2023
A Meta-analysis of Total Neoadjuvant Therapies Combining Chemoradiotherapy with Induction or Consolidated Chemotherapy for Locally Advanced Rectal Cancer.
Journal: Journal of gastrointestinal cancer
Published: September 09, 2022
Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity.
Journal: Frontiers in pharmacology
Published: March 21, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026